Record overview
Status and phase
Status: TERMINATED
Phase: PHASE1, PHASE2
Sponsor: TriSalus Life Sciences, Inc.
Condition: Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma
NCT05220722
Pressure Enabled Delivery of SD-101 With Checkpoint Blockade for Primary Liver Tumors
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: None
Results signal: Low Signal
Operational burden: rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
The decision was made to terminate the study after the completion of Phase 1b enrollment and not proceed with Phase 2. Trial termination was not due to patient safety or data concerns.